Detected ·
Galvanize Therapeutics
$130MSeries D
Galvanize Therapeutics closed an oversubscribed $130M Series D financing led by HealthQuest Capital to advance its pulsed electric field (PEF) platform for cancer and chronic lung disease.
- Website
- —
- —
- Amount
- $130 000 000 USD
- Stage
- Series D
- Event
- Funding round
- Detected
- 2026-11-20 00:27:13 UTC
- Signal ID
- d4869a94-592a-440b-9008-cb312e6d0db8
As the API returns it
{
"id": "d4869a94-592a-440b-9008-cb312e6d0db8",
"created_at": "2026-11-20T00:27:13.015894Z",
"company_name": "Galvanize Therapeutics",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 130000000,
"funding_currency": "USD",
"funding_stage": "series_d",
"message": "*Galvanize Therapeutics closed an oversubscribed $130M Series D financing led by HealthQuest Capital to advance its pulsed electric field (PEF) platform for cancer and chronic lung disease.*"
}